3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Phase NA
1
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
3
INDUSTRY
2
Study Type
Interventional
3
Sponsor
Cancer Type
Dermatologic
3
Conditions
Melanoma
1656
Skin Neoplasms
355
Lymphoma, T-Cell, Cutaneous
322
Carcinoma, Basal Cell
241
Mycosis Fungoides
227
Sezary Syndrome
209
Breast Neoplasms
196
Leukemia, Lymphocytic, Chronic, B-Cell
193
Lymphoma, Non-Hodgkin
192
Lymphoma, Follicular
187
Precursor Cell Lymphoblastic Leukemia-Lymphoma
183
Lymphoma, Large B-Cell, Diffuse
183
Lymphoma, B-Cell, Marginal Zone
182
Lymphoma, Mantle-Cell
181
Hodgkin Disease
175
Lymphoma
174
Burkitt Lymphoma
173
Uveal Melanoma
170
Lymphoma, Large-Cell, Immunoblastic
168
Multiple Myeloma
159
Keratosis, Actinic
146
Neoplasms
142
Leukemia, Myeloid, Acute
134
Neoplasm Metastasis
125
Lymphoma, Large-Cell, Anaplastic
125
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
123
Lung Neoplasms
120
Immunoblastic Lymphadenopathy
115
Leukemia, Myeloid, Accelerated Phase
113
Leukemia, Myeloid, Chronic-Phase
112
Interventions
cemiplimab
1
Transdermal Patch
1
Sirolimus
1
Prednisone
1
Everolimus
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
Cutaneous Squamous Cell Carcinoma
×
Dermatologic
×
Clear all
NCT05377905
2026-04-09
cSCC
University of Pittsburgh
Phase 1/2
Recruiting
48 enrolled
NCT07402616
2026-02-11
Ex Vivo Cutaneous SCC
Rigshospitalet, Denmark
Phase NA
Recruiting
30 enrolled
NCT04339062
2025-04-23
CONTRAC
Dana-Farber Cancer Institute
Phase 1/2
Completed
12 enrolled
13 charts